Correction to "Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up"

Abstract

Correction to: “Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up”. In the published article, several reference citation numbers were advanced by one position due to a material error.

Key Words: World Journal of Gastroenterology; Correction

Core Tip: This manuscript is to correct the reference citation of “Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up. World J Gastroenterol 2025; 31(18): 106670 [PMID: 40496357 DOI: 10.3748/wjg.v31.i18.106670]”.

CORRECTION

Correction to: “Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up” (World J Gastroenterol 2025; 31(18): 106670)[1].

In the published article[1], several reference citation numbers were advanced by one position due to a material error. The necessary corrections are as follows: (1) In Table 1, the references should be numbered 18-24 (instead of 17-23); (2) Figure 1 and Table 1 are updated, concordant with the references; (3) In the paragraph describing the Chinese Society of Clinical Oncology follow-up guidelines (originally ending with reference 23), the citation should be 24 (not 23); and (4) In the sentence “This model performed better than the guideline-based surveillance, with an AUC of 0.71-0.73 (57%-70% of detected cancers had the first three deciles of the score) vs 0.52-0.52[56]”, the citation should be 57 (instead of 56).

Figure 1 Heatmap of surveillance intensity by international guidelines. ACPGBI: Association of Coloproctology of Great Britain and Ireland; CEA: Carcinoembryonic antigen; CSCO: Chinese Society of Clinical Oncology; CT: Computed tomography; ESMO: European Society for Medical Oncology; JSCCR: Japanese Society for Cancer of the Colon and Rectum; NCCN: National Comprehensive Cancer Network.

Table 1 Comparison of international guidelines for colorectal cancer surveillance.

Surveillance method	ACPGBI (United Kingdom/Ireland)[18]	NCCN (United States)[19,20]	ESMO (Europe)[21,22]	JSCCR (Japan)[23]	CSCO (China)[24]
Clinical exam & CEA	Every 6 months (for 3 years)	Every 3-6 months (years 1-2), then every 6 months (up to 5 years)	Every 3-6 months (years 1-3), 6-12 months (years 4-5)	Every 3 months (years 1-3), every 6 months (years 4-5)	Stage I: Every 6 months Stage II-III: Every 3 months (years 1-3), then every 6 months (years 4-5)
CT	Minimum two evaluations within 3 years	Every 6-12 months (up to 5 years), Stage IV: Every 3-6 months (first 2 years), every 6-12 months up to 5 years	Every 6-12 months (years 1-3), annually (years 4-5)	Every 6 months (years 1-3), twice per year stage III, annually stages I-II (years 4-5)	Stage III/IV: Every 6-12 months (years 1-5), or in cases of increased CEA or abnormal ultrasound
Colonoscopy	Year 1, then every 5 years	Year 1; if adenoma present repeat at 1 year; if no adenoma, repeat at year 3, then every 5 years	Starting year 1, then every 3-5 years	Colon cancer: Years 1 & 3; rectal cancer: Years 1, 2 & 3	Year 1, then year 3, afterwards every 5 years
Additional imaging	Not routinely recommended	Not routinely recommended	Not routinely recommended	Not routinely recommended	Liver ultrasound recommended for stages I-II

CT: Computed tomography; CEA: Carcinoembryonic antigen; ACPGBI: The Association of Coloproctology of Great Britain and Ireland; NCCN: National Comprehensive Cancer Network; ESMO: European Society for Medical Oncology; JSCCR: Japanese Society for Cancer of the Colon and Rectum; CSCO: The Chinese Society of Clinical Oncology.

This error occurred during the final stages of editing when reference-management software fields were inactive. The text of the article is otherwise unchanged, and these corrections do not affect the study’s data or conclusions. We apologize for the oversight and issue this correction to uphold the accuracy of the scientific record.